Nancy E. Brutsché

10.6k total citations · 3 hit papers
34 papers, 7.8k citations indexed

About

Nancy E. Brutsché is a scholar working on Pharmacology, Biological Psychiatry and Cognitive Neuroscience. According to data from OpenAlex, Nancy E. Brutsché has authored 34 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 25 papers in Biological Psychiatry and 13 papers in Cognitive Neuroscience. Recurrent topics in Nancy E. Brutsché's work include Treatment of Major Depression (34 papers), Tryptophan and brain disorders (25 papers) and Functional Brain Connectivity Studies (12 papers). Nancy E. Brutsché is often cited by papers focused on Treatment of Major Depression (34 papers), Tryptophan and brain disorders (25 papers) and Functional Brain Connectivity Studies (12 papers). Nancy E. Brutsché collaborates with scholars based in United States, Czechia and Italy. Nancy E. Brutsché's co-authors include Carlos A. Zarate, David A. Luckenbaugh, Husseini K. Manji, Rezvan Ameli, Paul J. Carlson, Dennis S. Charney, Jaskaran Singh, Lobna Ibrahim, Nancy Diazgranados and Rodrigo Machado‐Vieira and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Molecular Psychiatry.

In The Last Decade

Nancy E. Brutsché

34 papers receiving 7.6k citations

Hit Papers

A Randomized Trial of an N-methyl-D-aspartate Antagonist ... 2006 2026 2012 2019 2006 2010 2012 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy E. Brutsché United States 29 6.0k 4.9k 2.8k 1.5k 1.4k 34 7.8k
Jaskaran Singh United States 31 5.2k 0.9× 4.1k 0.8× 2.5k 0.9× 1.2k 0.8× 2.1k 1.5× 94 8.1k
Amit Anand United States 37 3.0k 0.5× 2.5k 0.5× 2.5k 0.9× 2.7k 1.8× 1.9k 1.3× 127 8.1k
Dan A. Oren United States 30 2.5k 0.4× 2.1k 0.4× 1.9k 0.7× 754 0.5× 1.1k 0.8× 73 5.5k
Nancy Diazgranados United States 25 2.6k 0.4× 2.2k 0.5× 1.3k 0.5× 745 0.5× 1.2k 0.8× 79 4.5k
Chadi G. Abdallah United States 39 2.2k 0.4× 1.9k 0.4× 1.4k 0.5× 1.8k 1.2× 608 0.4× 112 5.5k
Mark J. Niciu United States 38 2.2k 0.4× 1.9k 0.4× 1.1k 0.4× 880 0.6× 702 0.5× 66 4.3k
Mounira Banasr United States 37 3.1k 0.5× 4.5k 0.9× 4.4k 1.6× 1.3k 0.8× 636 0.5× 60 9.4k
Ioline D. Henter United States 40 1.9k 0.3× 2.0k 0.4× 1.2k 0.4× 531 0.4× 1.4k 1.0× 81 4.8k
Paul J. Carlson United States 17 2.2k 0.4× 1.9k 0.4× 1.4k 0.5× 717 0.5× 699 0.5× 24 3.7k
Panos Zanos United States 29 2.7k 0.4× 2.2k 0.5× 2.1k 0.8× 572 0.4× 349 0.3× 71 4.8k

Countries citing papers authored by Nancy E. Brutsché

Since Specialization
Citations

This map shows the geographic impact of Nancy E. Brutsché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Brutsché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Brutsché more than expected).

Fields of papers citing papers by Nancy E. Brutsché

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy E. Brutsché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Brutsché. The network helps show where Nancy E. Brutsché may publish in the future.

Co-authorship network of co-authors of Nancy E. Brutsché

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy E. Brutsché. A scholar is included among the top collaborators of Nancy E. Brutsché based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy E. Brutsché. Nancy E. Brutsché is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duncan, Wallace C., Elizabeth E. Slonena, Nadia S. Hejazi, et al.. (2018). Are 24-hour motor activity patterns associated with continued rapid response to ketamine?. Neuropsychiatric Disease and Treatment. Volume 14. 2739–2748. 12 indexed citations
2.
Nugent, Allison C., Elizabeth D. Ballard, Todd D. Gould, et al.. (2018). Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Molecular Psychiatry. 24(7). 1040–1052. 167 indexed citations
3.
Evans, Jennifer W., Joanna Szczepanik, Nancy E. Brutsché, et al.. (2018). Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration. Biological Psychiatry. 84(8). 582–590. 128 indexed citations
4.
Niciu, Mark J., Bridget Shovestul, Cristan Farmer, et al.. (2018). Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. Journal of Affective Disorders. 232. 310–315. 97 indexed citations
5.
Ballard, Elizabeth D., Níall Lally, Erica M. Richards, et al.. (2017). Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Journal of Affective Disorders. 218. 195–200. 101 indexed citations
6.
Niciu, Mark J., Dipavo Banerjee, David A. Luckenbaugh, et al.. (2017). The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder. Journal of Psychopharmacology. 31(12). 1570–1577. 18 indexed citations
7.
Duncan, Wallace C., Elizabeth E. Slonena, Nadia S. Hejazi, et al.. (2017). Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine’s Rapid Antidepressant Properties. Biological Psychiatry. 82(5). 361–369. 65 indexed citations
8.
Ballard, Elizabeth D., David A. Luckenbaugh, Erica M. Richards, et al.. (2015). Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. Journal of Psychiatric Research. 68. 68–73. 56 indexed citations
9.
Niciu, Mark J., David A. Luckenbaugh, Dawn F. Ionescu, et al.. (2014). Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder. The International Journal of Neuropsychopharmacology. 18(1). 45 indexed citations
10.
Luckenbaugh, David A., Mark J. Niciu, Dawn F. Ionescu, et al.. (2014). Do the dissociative side effects of ketamine mediate its antidepressant effects?. Journal of Affective Disorders. 159. 56–61. 220 indexed citations
11.
Carlson, Paul J., Nancy Diazgranados, Allison C. Nugent, et al.. (2013). Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study. Biological Psychiatry. 73(12). 1213–1221. 138 indexed citations
12.
Zarate, Carlos A., Nancy E. Brutsché, Gonzalo Laje, et al.. (2012). Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression. Biological Psychiatry. 72(4). 331–338. 223 indexed citations
13.
Duncan, Wallace C., Simone Sarasso, Fabio Ferrarelli, et al.. (2012). Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. The International Journal of Neuropsychopharmacology. 16(2). 301–311. 177 indexed citations
14.
Zarate, Carlos A., Daniel C. Mathews, Lobna Ibrahim, et al.. (2012). A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression. Biological Psychiatry. 74(4). 257–264. 203 indexed citations
15.
Zarate, Carlos A., Nancy E. Brutsché, Lobna Ibrahim, et al.. (2012). Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial. Biological Psychiatry. 71(11). 939–946. 607 indexed citations breakdown →
16.
Ibrahim, Lobna, Nancy Diazgranados, Jose Franco‐Chaves, et al.. (2012). Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study. Neuropsychopharmacology. 37(6). 1526–1533. 242 indexed citations
17.
Ibrahim, Lobna, Nancy Diazgranados, Nancy E. Brutsché, et al.. (2012). A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder. Journal of Clinical Psychopharmacology. 32(4). 551–557. 175 indexed citations
18.
Luckenbaugh, David A., Lobna Ibrahim, Nancy E. Brutsché, et al.. (2012). Family history of alcohol dependence and antidepressant response to an N‐methyl‐D‐aspartate antagonist in bipolar depression. Bipolar Disorders. 14(8). 880–887. 54 indexed citations
19.
Diazgranados, Nancy, Lobna Ibrahim, Nancy E. Brutsché, et al.. (2010). A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression. Archives of General Psychiatry. 67(8). 793–793. 734 indexed citations breakdown →
20.
Diazgranados, Nancy, Lobna Ibrahim, Nancy E. Brutsché, et al.. (2010). Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder. The Journal of Clinical Psychiatry. 71(12). 1605–1611. 454 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026